Myelitis due to anti-phospholipid syndrome (Q88830): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 15:13, 15 August 2026
Inflammation of the spinal cord in association with anti-phospholipid syndrome which may be temporally acute, subacute or chronic and anatomically partial or complete. Clinical features include paraplegia, quadriplegia, sensory loss appropriate to the level of the spinal cord involved and sphincter dysfunction. Other clinical features of anti-phospholipid syndrome may be present. Diagnosis may be aided by spinal imaging, spinal fluid analysis and serological testing for antibodies associated with anti-phospholipid syndrome including anti-cardiolipin, beta2-glycoprotein and lupus anticoagulant.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1850122136 |
||
| English | Myelitis due to anti-phospholipid syndrome |
Inflammation of the spinal cord in association with anti-phospholipid syndrome which may be temporally acute, subacute or chronic and anatomically partial or complete. Clinical features include paraplegia, quadriplegia, sensory loss appropriate to the level of the spinal cord involved and sphincter dysfunction. Other clinical features of anti-phospholipid syndrome may be present. Diagnosis may be aided by spinal imaging, spinal fluid analysis and serological testing for antibodies associated with anti-phospholipid syndrome including anti-cardiolipin, beta2-glycoprotein and lupus anticoagulant. |
Statements
CID11:ID_1850122136
0 references
dki-india-ID_1850122136
0 references
Concluído
0 references
13 August 2026
0 references
